Cargando…

ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia

MLL-rearranged acute myeloid leukemia (AML) remains a fatal disease with a high rate of relapse and therapeutic failure due to chemotherapy resistance. In analysis of our Affymetrix microarray profiling and chromatin immunoprecipitation (ChIP) assays, we found that ALOX5 is especially down-regulated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yungui, Skibbe, Jennifer R., Hu, Chao, Dong, Lei, Ferchen, Kyle, Su, Rui, Li, Chenying, Huang, Hao, Weng, Hengyou, Huang, Huilin, Qin, Xi, Jin, Jie, Chen, Jianjun, Jiang, Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431828/ https://www.ncbi.nlm.nih.gov/pubmed/28500307 http://dx.doi.org/10.1038/s41598-017-01913-y

Ejemplares similares

Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC
por: Li, Chenying, et al.
Publicado: (2020)

miR-550-1 functions as a tumor suppressor in acute myeloid leukemia via the hippo signaling pathway
por: Hu, Chao, et al.
Publicado: (2020)

Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
por: Jiang, Xi, et al.
Publicado: (2017)

Author Correction: Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
por: Jiang, Xi, et al.
Publicado: (2018)

FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML
por: Sheng, Yue, et al.
Publicado: (2020)

miR-150: targeting MLL leukemia
por: Jiang, Xi, et al.
Publicado: (2012)

RNA binding proteins in MLL-rearranged leukemia
por: Tran, Tiffany M., et al.
Publicado: (2022)

Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia
por: Oliveira, Tiago, et al.
Publicado: (2021)

Recognition of RNA N(6)-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation
por: Huang, Huilin, et al.
Publicado: (2018)

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
por: Feng, Zizhen, et al.
Publicado: (2016)

MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches
por: Winters, Amanda C., et al.
Publicado: (2017)

Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia
por: Hurtz, Christian, et al.
Publicado: (2019)

Identification of co-expressed genes associated with MLL rearrangement in pediatric acute lymphoblastic leukemia
por: Zhang, Hao, et al.
Publicado: (2020)

Identification of hub genes and molecular mechanisms in infant acute lymphoblastic leukemia with MLL gene rearrangement
por: Zhang, Hao, et al.
Publicado: (2019)

MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
por: Zangrando, Andrea, et al.
Publicado: (2009)

Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia
por: van der Linden, Marieke H., et al.
Publicado: (2015)

KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements
por: Au, Yan Zi, et al.
Publicado: (2021)

Replication stress in MLL-rearrangements
por: Milyavsky, Michael, et al.
Publicado: (2015)

The landscape of somatic mutations in Infant MLL rearranged acute lymphoblastic leukemias
por: Andersson, Anna K, et al.
Publicado: (2015)

The developmental stage of the hematopoietic niche regulates lineage in MLL-rearranged leukemia
por: Rowe, R. Grant, et al.
Publicado: (2019)

Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
por: Brzezinka, Krzysztof, et al.
Publicado: (2019)

Prognostic value and outcome for acute lymphocytic leukemia in children with MLL rearrangement: a case-control study
por: Qiu, Kun-yin, et al.
Publicado: (2022)

DOT1L Inhibition Sensitizes MLL-Rearranged AML to Chemotherapy
por: Liu, Wei, et al.
Publicado: (2014)

Decitabine mildly attenuates MLL‐rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo‐sensitizer
por: Schneider, Pauline, et al.
Publicado: (2020)

Erratum: Replication stress in MLL-rearrangements
por: Milyavsky, Michael, et al.
Publicado: (2016)

MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals
por: Brassesco, María Sol, et al.
Publicado: (2009)

ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia
por: Germano, Giuseppe, et al.
Publicado: (2017)

Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
por: Chan, Anthony K. N., et al.
Publicado: (2019)

Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged Leukemia
por: Barve, Aditya, et al.
Publicado: (2019)

PROM1 and CTGF Expression in Childhood MLL-Rearrangement Acute Lymphoblastic Leukemia
por: Wang, Lu-lu, et al.
Publicado: (2022)

Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia
por: Fischer, Jacqueline, et al.
Publicado: (2023)

Transcription factor MEF2D is required for the maintenance of MLL-rearranged acute myeloid leukemia
por: Zhao, Lianzhong, et al.
Publicado: (2021)

Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency
por: Muñoz-López, Alvaro, et al.
Publicado: (2016)

MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia
por: Itskovich, Svetlana S., et al.
Publicado: (2020)

The “Never-Ending” Mouse Models for MLL-Rearranged Acute Leukemia Are Still Teaching Us
por: Ottersbach, Katrin, et al.
Publicado: (2018)

Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
por: Tsakaneli, Alexia, et al.
Publicado: (2021)

Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax
por: Fidyt, Klaudyna, et al.
Publicado: (2022)

Preferential induction of MLL(Mixed Lineage Leukemia) rearrangements in human lymphocyte cultures treated with etoposide
por: Brassesco, María Sol, et al.
Publicado: (2009)

Development of a Multi-Step Leukemogenesis Model of MLL-Rearranged Leukemia Using Humanized Mice
por: Moriya, Kunihiko, et al.
Publicado: (2012)

Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia
por: Chen, Lili, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dov8klrvkpvbtkmvvqceosh946